COVAX
>
嚴重特殊傳染性肺炎疫苗實施計劃是一項旨在讓全球公平獲取嚴重特殊傳染性肺炎疫苗的倡議，該協議由聯合國兒童基金會、GAVI、世界衛生組織、流行病防備創新聯盟等組織牽頭發起。該協議也是獲取COVID-19工具加速計劃 的三大支柱之一。該計劃已於2023年12月31日結束。 維基百科
相關問題
What is COVAX?
Why did COVAX fail?
Who is paying for COVAX?
Is Pfizer part of COVAX?
COVAX was the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator. The ACT Accelerator is a ground-breaking global collaboration to accelerate the ...
Explore COVAX ... A historic multilateral effort co-led by Gavi, CEPI, WHO and UNICEF from 2020 through 2023, COVAX pushed to centre vaccine equity at the heart ...
COVAX Objectives 2022. COVAX aspires to enable equitable, full vaccination of all adult and adolescent populations globally to reduce the impact of the ongoing ...
2020年9月3日 · The principal role of the COVAX Facility is to maximise the chances of people in participating countries getting access to COVID-19 vaccines as ...
COVAX (the vaccines pillar of the ACT-Accelerator) aimed to accelerate the development and manufacture of COVID-19 vaccines, and to make sure that they reach ...
2023年12月19日 · COVAX, the multilateral mechanism for equitable global access to COVID-19 vaccines launched in 2020, will draw to a close on 31 December.
COVID-19 Vaccines Global Access, abbreviated as COVAX, is a worldwide initiative aimed at equitable access to COVID-19 vaccines directed by the GAVI vaccine ...
The PAHO Revolving Fund is the mechanism designated by COVAX to procure the vaccines on behalf of the countries in the region.
CEPI led COVAX's vaccine research and development work, investing in R&D and manufacturing across one of the world's largest portfolios of COVID-19 vaccines ...
2021年2月18日 · This issue brief provides an overview of COVAX, the global mechanism to secure and deliver COVID-19 vaccines. The brief details COVAX's ...